Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/80295

Registo completo
Campo DCValorIdioma
dc.contributor.authorFreitas, Ana Sofiapor
dc.contributor.authorCosta, Marta Sílvia Freitaspor
dc.contributor.authorPontes, Olíviapor
dc.contributor.authorSeidel, Veroniquepor
dc.contributor.authorProença, M. Fernanda R. P.por
dc.contributor.authorCardoso, Susana M.por
dc.contributor.authorOliveira, Rui Pedro Soares depor
dc.contributor.authorBaltazar, Fátimapor
dc.contributor.authorAlmeida Aguiar, Cristinapor
dc.date.accessioned2022-10-24T08:45:09Z-
dc.date.available2022-10-24T08:45:09Z-
dc.date.issued2022-06-22-
dc.identifier.citationFreitas, A.S.; Costa, M.; Pontes, O.; Seidel, V.; Proença, F.; Cardoso, S.M.; Oliveira, R.; Baltazar, F.; Almeida-Aguiar, C. Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells. Molecules 2022, 27, 4001. https://doi.org/10.3390/molecules27134001por
dc.identifier.urihttps://hdl.handle.net/1822/80295-
dc.description.abstractRenal cell carcinoma is the most lethal cancer of the urological system due to late diagnosis and treatment resistance. Propolis, a beehive product, is a valuable natural source of compounds with bioactivities and may be a beneficial addition to current anticancer treatments. A Portuguese propolis sample, its fractions (<i>n</i>-hexane, ethyl acetate, <i>n</i>-butanol and water) and three subfractions (<b>P1</b>–<b>P3</b>), were tested for their toxicity on A498, 786-O and Caki-2 renal cell carcinoma cell lines and the non-neoplastic HK2 kidney cells. The ethyl acetate fraction showed the strongest toxicity against A498 (IC<sub>50</sub> = 0.162 µg mL<sup>−1</sup>) and 786-O (IC<sub>50</sub> = 0.271 µg mL<sup>−1</sup>) cells. With similar toxicity against 786-O, <b>P1</b> (IC<sub>50</sub> = 3.8 µg mL<sup>−1</sup>) and <b>P3</b> (IC<sub>50</sub> = 3.1 µg mL<sup>−1</sup>) exhibited greater effect when combined (IC<sub>50</sub> = 2.5 µg mL<sup>−1</sup>). Results support the potential of propolis and its constituents as promising coadjuvants in renal cell carcinoma treatment.por
dc.description.sponsorshipAna Freitas acknowledge the financial support provided by national funds through FCT-Portuguese Foundation for Science and Technology (PD/BD/128276/2017), under the Doctoral Programme “Agricultural Production Chains–from fork to farm” (PD/00122/2012) and from the European Social Funds and the Regional Operational Programme Norte 2020. This study was also supported by CITAB research unit (UIDB/04033/2020) and by the “Contrato-Programa” UIDB/04050/2020 funded by national funds through the FCT I.P. An acknowledge also to the University of Aveiro and to Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES) for financial support to the associated laboratory LAQV-REQUIMTE (project reference UIDB/50006/2020), through national funds and co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER), within the PT2020 Partnership Agreement. We also acknowledge the financial support from University of Minho, Fundação para a Ciência e a Tecnologia (FCT) and FEDERCOMPETE for financial support through Centro de Química (UID/QUI/00686/2013 and UID/QUI/0686/2016), for the PhD grant awarded to Olívia Pontes (SFRH/BD/128850/2017). The NMR spectrometer Bruker Avance III 400 is part of the National NMR Network (RNRMN) and was purchased within the framework of the National Program for Scientific Re-equipment, contract REDE/1517/RMN/2005 with funds from POCI 2010 (FEDER) and FCT. This work has been funded by National funds, through the Foundation for Science and Technology (FCT)-project UIDB/50026/2020 and UIDP/50026/2020.por
dc.language.isoengpor
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)por
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/PD%2FBD%2F128276%2F2017/PTpor
dc.relationPD/00122/2012por
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04033%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04050%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50006%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FQUI%2F00686%2F2013/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FQUI%2F0686%2F2016/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F128850%2F2017/PTpor
dc.relationREDE/1517/RMN/2005por
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50026%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50026%2F2020/PTpor
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subjectPropolispor
dc.subjectFractionationpor
dc.subjectPhenolic compoundspor
dc.subjectPectolinarigeninpor
dc.subjectCytotoxic activitypor
dc.subjectRenal cell carcinomapor
dc.titleSelective cytotoxicity of Portuguese propolis ethyl acetate fraction towards renal cancer cellspor
dc.typearticlepor
dc.peerreviewedyespor
dc.relation.publisherversionhttps://www.mdpi.com/1420-3049/27/13/4001por
oaire.citationStartPage1por
oaire.citationEndPage13por
oaire.citationIssue13por
oaire.citationVolume27por
dc.date.updated2022-07-08T11:55:27Z-
dc.identifier.eissn1420-3049-
dc.identifier.doi10.3390/molecules27134001por
dc.identifier.pmid35807247por
dc.subject.wosScience & Technologypor
sdum.journalMoleculespor
oaire.versionVoRpor
dc.identifier.articlenumber4001por
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals
CBMA - Artigos/Papers

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
molecules-27-04001-v2.pdf1,52 MBAdobe PDFVer/Abrir

Este trabalho está licenciado sob uma Licença Creative Commons Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID